1-6 of 6
Karen MacDonald, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Conversion to Biosimilar Pegfilgrastim-Jmdb from Pegfilgrastim with on-Body Injector Device in Diffuse Large B-Cell Lymphoma: Simulation Modeling of Cost-Savings and Budget-Neutral Expanded Access to Prophylaxis and Anti-Neoplastic Therapy Considering Device Failure Rate

Ali McBride, PharmD, MS, Karen MacDonald, PhD, Ivo Abraham, PhD RN
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-142749
Published: 2020
Journal Articles

Simulation Modeling of Cost-Savings from Conversion to Biosimilar Pegfilgrastim-Cbqv for the Prophylaxis of Chemotherapy-Induced Neutropenia, and Budget-Neutral Expanded Access to Prophylaxis and Anti-Neoplastic Therapy from Derived Cost-Savings in Non-Hodgkin Lymphoma

Ali McBride, PharmD, MS, Karen MacDonald, PhD, Ivo Abraham, PhD RN
Journal: Blood
Blood (2020) 136 (Supplement 1): 24–25.
https://doi.org/10.1182/blood-2020-136810
Published: 2020
Journal Articles

Subcutaneous Versus Intravenous Rituximab in Non-Hodgkin Lymphoma Treated with R-CHOP: Economic Modeling for the US

Ali McBride, PharmD, MS, Sanjeev Balu, PhD, Kim Campbell, PharmD, Karen MacDonald, PhD, Ivo Abraham, PhD RN
Journal: Blood
Blood (2018) 132 (Supplement 1): 4776.
https://doi.org/10.1182/blood-2018-99-113283
Published: 2018
Journal Articles

Cost Simulation for Febrile Neutropenia Hospitalization in the US Due to Pegfilgrastim on-Body Injector Failure Compared to Single-Injection Pegfilgrastim and Daily Injections with Reference and Biosimilar Filgrastim in Non-Hodgkin Lymphoma

Ali McBride, PharmD,MS, Andriy Krendyukov, MD MBA, Nicola Mathieson, Kim Campbell, PharmD, Sanjeev Balu, PhD, Karen MacDonald, PhD, Ivo Abraham, PhD RN
Journal: Blood
Blood (2018) 132 (Supplement 1): 2251.
https://doi.org/10.1182/blood-2018-99-116315
Published: 2018
Journal Articles

Adherence to Tyrosine Kinase Inhibitor Therapy in Patients with Chronic Myeloid Leukemia: Meta-Analyses of Prevalence Rates By Measurement Method

Ziyad Alrabiah, PharmD, BCPS, Abdulaziz Alhossan, PharmD, BCPS, Seongseok Yun, MD PhD, Karen MacDonald, PhD, Ivo Abraham, PhD
Journal: Blood
Blood (2016) 128 (22): 3610.
https://doi.org/10.1182/blood.V128.22.3610.3610
Published: 2016
Journal Articles

Efficacy of Same-Day Vs. Next-Day Pegfilgrastim for the Prevention of Chemotherapy-Induced (Febrile) Neutropenia (CIN/FN): A Meta-Analysis

Reem Diri, PharmD, Ali McBride, PharmD,MS, Christopher Lee, PhD, Alaa Bagalagel, PharmD, Hussain Bakhsh, PharmD, Daniel O. Persky, MD, Karen MacDonald, PhD, Jennifer Martin, MA, Ivo Abraham, PhD
Journal: Blood
Blood (2015) 126 (23): 4764.
https://doi.org/10.1182/blood.V126.23.4764.4764
Published: 2015